Homepage | Istituto Neuroscienze Firenze
I cherish ethical principles first, and I commit to care for each person as a whole, respecting his or her dignity in each phase of life.
A history of innovations
All of the work that Dr. Stefano Pallanti pursues originates from a sincere passion to offer the best therapeutic option for each person’s recovery and from his everlasting aspiration to disentangle complex and difficult cases.
Dr. Pallanti is a "Physician-Neuroscientist" who combines the European tradition of Phenomenology with the “evidence-based” approach of the US scientific medical community.
The Pallanti Method
The Pallanti Method represents a method of Translational Clinical Neuroscience, a systematic approach to health care through the analysis and translation of clinical symptoms into their functional meaning.
The Pallanti Method seeks to reconcile a total respect for the person and the use of cutting-edge techniques and therapies, useful for improving performance and preventing long-term disorders.
The fruits of scientific research offered to patients without waiting for bureaucratic procedures.
Dr. Stefano Pallanti founded the Istituto di Neuroscienze in 1989 to create a center that introduces scientifically validated evidence of innovation in the treatment without waiting for the bureaucratic process.
The Istituto di Neuroscienze has not only anticipated the changing times to apply innovative treatments but has contributed with is original research tto the evolution of treatments.
Dr. Stefano Pallanti founded the Istituto di Neuroscienze in 1989 to create a center that introduces scientifically validated evidence of innovation in the treatment. Only the latest innovations validated by science are offered; no "experimental" treatments are made.
Dr. Pallanti starts prescribing off-label SSRI drugs that AIFA (Italian Drug Agency) approved in 2001. Dr. Pallanti's patients received these innovative treatments 17 years before the others.
Foundation of the Istituto di Neuroscienze.
Opening of the Day-Care Center for patients and their families.
Start of Intravenous Therapy at the Day-Care Center.
Introduction of Plasma Tests for diagnostics.
Adoption of a new diagnosis of ADHD.
Starting Life-span ADHD program for children and adults.
Starting a program for behavioral addictions and pathological gambling.
Start of Neuromodulation therapies ― Light Therapy and PESF.
Starting an ADHD program for adults.
Starting a PANDAS-PANS program.
Introduction of pharmacological therapy for Behavioral Addictions.
Start of Neuromodulation clinical therapies ― rTMS and tDCS.
The FDA approval of these therapies only took place in 2008: the Istituto di Neuroscienze was an absolute avant-garde in the world.
Harvard University started using rTMS only in 2016, 11 years after Dr. Pallanti.
Start using intravenous secretin for the treatment of autism.
Introduction of Standard Pharma Supplements for Holistic Care.
Started publishing scientific peer-reviewed articles on clinical use of TMS.
Conducting the Master Course in Mindfulness.
Foundation of the Clinical TMS Society (California, USA) as a founding member.
Introduction of Gut-screening into diagnostics.
Introduction of Psychotherapy combined with Neuromodulation Therapies.
Introduction of RDoC approach based on connectivity in association with Harvard University.
Introduction of Genetic Tests in diagnostics.
Introduction of Theta-Burst TMS stimulation protocols.
Introduction of rTMS for behavioral addictions in collaboration with Harvard University.
The Istituto di Neuroscienze starts offering another cutting-edge therapy: Photo-Bio-Modulation.
Foundation of the Accademia delle Terapie Naturali (Natural Therapies Academy) as a founding member.
Introduction of Multi-Session Theta-Burst Stimulation (SNT).
Introduction of non-invasive Vagus Nerve Stimulation (VNS).
Introduction of Mindfulness associated with Neuromodulation Therapies (TMS).
- March 2021
Publication of one of the first peer-reviewed scientific articles on Covid-19 in the world on how to prevent Neurocovid.
Use of Esketamine Spray (Spravato) and Ketamine Infusion for the treatment of resistant depression.
Publication of major studies on the use of TMS Theta-Burst for Gambling Disorder and tDCS for Mild Cognitive Impairment.
Introduction of Neurofeedback for ADHD.
Personalized therapies for unique care pathways
Precision psychiatry is this: for each person, a cure is designed only for them. Because each person is unique in terms of genetic characteristics, microbiome, family and social environment. In particular, COVID-19 has taught us that everyone is a micro-ecosystem in open communication with the world.
Everything starts in the brain. We can achieve the best possible sports performance using neuroscientific knowledge and methods.
― Clinical studies and scientific research;
― Development of the precision diagnosis program for hospitals and nursing homes;
― Development of cutting-edge care projects and programs for hospitals and nursing homes;
― Development of product growth strategies for pharmaceutical and biotech companies;
― Sports neuroscience: development of strategies and technical support to improve performance and to prevent brain damage for sports teams and clubs;
― Development of stress prevention and suicide prevention programs within hospitals, nursing homes, schools, and companies.
― For Health Care Providers: the notions useful for providing a TMS service for substance and behavioral addictions;
― For Health Care Professionals;
― CME courses.
Biennial course on Anxiety Disorders organized by the European College of Neuropsychopharmacology
A unique opportunity to expand your knowledge and experience in the field of Anxiety Disorders.
Dr. Stefano Pallanti will lecture on Neuromodulation Therapies during the 4th module of the course.
4th WASAD International Congress
On September 12 and 13 2023, Dr. Pallanti participated as an expert speaker in the fourth International Congress of the World Association for Anxiety and Related Stress Disorders (WASAD). His talks were on ADHD and PANDAS Syndrome.
The Istituto di Neuroscienze becomes a training site for Massachusetts General Hospital
Dr. Stefano Pallanti's Istituto di Neuroscienze has been appointed as the training site for the elective activities of the Massachusetts General Hospital, the teaching hospital of the Harvard Medical School.
Remote visits via Skype
Dr. Stefano Pallanti is a pioneer in telemedicine, recognizing the potential of this remote visiting modality since 2008. Since then, more than 1,500 patients from all over Italy and Abroad have been making remote visits via Skype with Dr. Pallanti and his collaborators of the Istituto di Neuroscienze, to benefit from our experience regardless of their geographical location!
Choose specialized visits via Skype with Dr. Pallanti and start your healing journey, wherever you are!
For our services you can pay from home or with your phone via PayPal or Debit/Credit Card.